If you're an HR or benefits professional seeking cancer resources for your employees, or a consultant looking to provide best-in-class cancer support for your clients, share a few details below. We’ll reach out to help your company get started.
If you’re an employee looking for your AccessHope benefit, call 800.423.3232 and select Option 1.
AccessHope and Johns Hopkins Medicine's Kimmel Cancer Center announce a collaboration, extending access to cancer expertise in the Mid-Atlantic United States and beyond.
Read moreNew Study from AccessHope Affirms Cancer Subspecialist ... Read more
AccessHope Announces Foundational Partnership with Johns ... Read more
DUARTE, Calif. – July 20, 2023: Read more
12/05/23 - Empowered Patient
AccessHope’s Chief Medical Officer, Todd Sachs, M.D., shares the key factors influencing the disparities gap in cancer care. He outlines three concerns: first, barriers to accessing the necessary screenings to diagnose cancer earlier; second, geographical barriers preventing patients from accessing cancer subspecialist expertise; and finally, a widening knowledge gap between academic medicine and community oncology. Read more
11/15/23 - Chief Healthcare Executive®
In an interview with Chief Healthcare Executive®, City of Hope’s President of Health Innovation and Policy, and Chair of the Board, AccessHope, discusses solutions to cancer care health disparities, addressing underserved communities, changing health policy, and improving access to quality cancer care. Too many patients in underserved communities don’t live near a National Cancer Institute-designated cancer center, Levine says. AccessHope facilitates people to obtain better care while still seeing their own doctors. Read more
11/14/23 - Journal of Personalized Medicine
AccessHope’s Vice President, Value and Strategy and Medical Director, GI Oncology Dr. Afsaneh Barzi sat down with Alison Kanski at Precision Medicine Online to discuss the latest findings from a new pancreatic cancer study published in the Journal of Personalized Medicine that highlights AccessHope’s clinical impact on cases of pancreatic adenocarcinoma. Read more
03/30/23 - Emory Healthcare
As published in the New England Journal of Medicine (NEJM), a targeted therapy for children with high-risk Hodgkin lymphoma (HL) was shown to significantly reduce relapse rates – by 10% – when tested in a large multicenter clinical trial conducted by the Children’s Oncology Group (COG) and led by pediatric oncologists at Winship Cancer Institute of Emory University, Children’s Healthcare of Atlanta and Roswell Park Comprehensive Cancer Center. Read more
03/21/23 - City of Hope
City of Hope’s Idoroenyi Amanam, M.D. is getting noticed for his abilities, including recognition from MPN Research Foundation, and National Institutes of Health. Amanam’s focuses on the relative obscurity of MPNs, a group of blood cancers called myeloproliferative neoplasms (MPN). MPNs are remarkably rare, as well as the expertise in the field. A typical oncologist might never see a case of MPN. Read more
02/13/23 - Northwestern Medicine
Treatments for medical conditions like cancer and heart disease can leave lasting physical and mental scars. Research showed that 58% of people who underwent treatment for cancer had a negative body image as a result. As a cancer survivor herself, Dr. Bernhardt, a board-certified clinical health psychologist at Northwestern Medicine, shares advice on how to cope with body image issues after a major medical event. Read more
For the latest innovations and updates from AccessHope, simply share your address with us.
Johns Hopkins Medicine joins AccessHope to extend nationwide access to cancer expertise
